Neutrophil-Lymphocyte Ratio (NLR): Calculation and Ranges

Updated October 2026: refreshed the research on NLR as an inflammatory and prognostic marker, added published reference values and confounders, corrected the calculation, and replaced outdated links and consumer app instructions.

Conventional vs. Functional Lab Testing Ranges and Markers

The neutrophil-lymphocyte ratio (NLR) is a simple calculation from a routine blood test that is used across oncology, cardiology, infectious disease and critical care, and is widely tracked in functional and longevity medicine as a low-cost window into systemic inflammation. Conventional lab testing is a great screening tool for diseases and disorders, but looking at the same results through a functional lens can provide insight into the health trend of a patient long before a disease is discovered.

Functional ranges and ratios, viewed as trends over time, can help a clinician see where a patient is heading before a diagnosis is made, which creates an earlier window for lifestyle intervention, follow-up testing and prevention.

What Is NLR?

The neutrophil-lymphocyte ratio is calculated from a complete blood count (CBC) with differential, a low-cost, low-barrier test that is usually covered by insurance and is also available through direct-to-consumer lab services. Because neutrophils drive the innate inflammatory response and lymphocytes reflect adaptive immunity, NLR is considered an indicator of systemic inflammation and of the balance between inflammation and immune capacity.

What Do Neutrophils and Lymphocytes Do?

Neutrophils are white blood cells (WBCs) and part of the innate immune system, the fast, nonspecific first line of defense that we are born with. They are made in the bone marrow, circulate in the blood for a short time and migrate into tissues at sites of infection or injury (Summers et al., 2010). In a typical adult differential, neutrophils make up about 40% to 60% of WBCs (MedlinePlus).

Lymphocytes, mainly B cells and T cells, are another type of white blood cell and make up about 20% to 40% of WBCs. They are part of the adaptive or acquired immune system: they are more specific in their targets, they provide immune memory after exposure to a virus or other pathogen, and they are the cells that vaccines are designed to train. They circulate in the blood and are concentrated in lymphatic tissues such as the lymph nodes, spleen and thymus.

Together, neutrophils and lymphocytes protect the body from pathogens and other threats. Inflammation brings immune cells and nutrients to the site of injury and helps keep an infection from spreading. When inflammation becomes chronic, the balance between the two cell types shifts, and that shift is what the NLR captures.

How Can the Neutrophil-Lymphocyte Ratio Benefit My Patients?

A higher NLR suggests that inflammatory activity is outpacing adaptive immune capacity, whether from an acute stressor or a chronic process working in the background. The evidence base has grown considerably since this ratio first became popular in functional medicine:

Cancer prognosis. A meta-analysis of 100 studies and more than 40,000 patients found that an NLR above the median cutoff of 4 was associated with worse overall survival across solid tumors (hazard ratio 1.81) (Templeton et al., 2014). A meta-analysis in breast cancer found that an elevated preoperative NLR was associated with poorer prognosis (Duan et al., 2018), and in gastric cancer, combining NLR with C-reactive protein (CRP) in a score known as COC-NLR predicted postoperative survival better than either marker alone (Guo et al., 2018). A systematic review of gastrointestinal cancers reached similar conclusions about NLR as a prognostic marker (Bowen et al., 2017). This is why the ratio is often used by integrative practitioners who work with cancer patients.
Cardiovascular risk. NLR has been linked to cardiac arrhythmias and to short- and long-term mortality in patients with acute coronary syndromes (Afari and Bhat, 2016). In analyses of more than 60,000 participants across five randomized trials (CANTOS, JUPITER, SPIRE-1, SPIRE-2 and CIRT), baseline NLR independently predicted major cardiovascular events and death. In CANTOS, each quartile increase in NLR was associated with a 20% higher risk of major adverse cardiovascular events. Lipid-lowering drugs did not change NLR, while anti-inflammatory therapy with canakinumab lowered it (Adamstein et al., 2021).
Mortality in the general population. In US National Health and Nutrition Examination Survey (NHANES) data from 1999 to 2014, each quartile increase in NLR was associated with 14% higher overall mortality, as well as higher mortality from heart disease, chronic lower respiratory disease, influenza and pneumonia, and kidney disease (Song et al., 2021).
Acute infection. NLR rises quickly with infection, sepsis and critical illness. During the COVID-19 pandemic, a meta-analysis found that NLR had good predictive value for both disease severity and mortality (Li et al., 2020).

NLR is not a diagnostic test on its own. It is a sensitive but nonspecific marker of stress and inflammation (Zahorec, 2021), so it works best as a trend, read alongside other inflammatory markers such as high-sensitivity CRP and the full clinical picture.

How Do I Calculate the Neutrophil-Lymphocyte Ratio (NLR)?

To calculate NLR, divide the absolute neutrophil count by the absolute lymphocyte count from the same CBC with differential:

NLR = absolute neutrophil count / absolute lymphocyte count

For example, a patient with 4,000 neutrophils and 2,000 lymphocytes per microliter has an NLR of 2.0. Dividing the neutrophil percentage by the lymphocyte percentage gives the same result.

Seeing the trend over time provides deeper insight than any single value. A rising NLR can be a warning sign that it is time to look for an underlying cause, adjust diet or lifestyle interventions, or consider further testing.

What Do the Numbers Mean?

There is no single, universally accepted reference range, and published cutoffs vary by population and clinical setting. Useful reference points include:

In 413 healthy working adults, the normal NLR range was 0.78 to 3.53, with a mean of 1.65 (Forget et al., 2017).
In a nationally representative sample of 9,427 US adults, the average NLR was 2.15. Non-Hispanic Black participants had significantly lower mean values (1.76) than non-Hispanic White participants (2.24), and people with diabetes, cardiovascular disease or a smoking history had higher values (Azab et al., 2014).
A 2021 review proposed that an NLR between 1 and 2 is normal in adults, that values of about 2.3 to 3.0 are a gray zone that may serve as an early warning, and that values above 3.0 or below 0.7 are pathological (Zahorec, 2021).

Many functional medicine practitioners aim for an NLR of about 2 or lower, meaning no more than roughly twice as many neutrophils as lymphocytes. For example, a differential of about 55% neutrophils and 30% lymphocytes gives an NLR of about 1.8. A widening gap between neutrophils and lymphocytes points toward a higher inflammatory burden.

When interpreting NLR, account for factors that shift it independent of chronic inflammation, including age, race and ethnicity, medications such as corticosteroids, smoking, acute illness, chronic disease and psychological or physiological stress (Zahorec, 2021).

A reversed pattern also deserves attention. A low NLR, with lymphocytes elevated and neutrophils lowered, is common with viral infections, but persistent changes can also reflect conditions such as lymphocytic leukemia and warrant follow-up (MedlinePlus).

As with any lab value, NLR should be interpreted in the context of the patient's full history, symptoms and other results.

How Can I Track NLR Across My Patients?

Because NLR is most useful as a trend, you need every CBC in one place. In Heads Up, lab PDFs are extracted automatically into each client's longitudinal record, and results flow in from lab integrations such as Labcorp and Quest, so neutrophil and lymphocyte counts sit alongside wearable, device and EHR data. Threshold alerts flag values outside the ranges you set, and the AI copilot's pre-visit briefs summarize what has changed since the last visit. For more on building a panel around markers like this, see our longevity biomarker panel guide and how to digitize PDF lab reports automatically.

See how Heads Up tracks CBC trends and other biomarkers for your clients: request a demo.

Resources

See how clinics use Heads Up

Unify labs, wearables and EHR data into one AI-assisted view. Book a walkthrough tailored to your practice.

Request A Demo

Calculating the Neutrophil-Lymphocyte Ratio (NLR) as Immune and Inflammatory Markers